id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2009-N-0026-0002,FDA,FDA-2009-N-0026,Apothecon et al.; Withdrawal of Approval of 103 New Drug Applications and 35 Abbreviated NewDrug Applications; Correction,Notice,NCR-Notice of Correction,2009-09-25T04:00:00Z,2009,9,2009-09-25T04:00:00Z,,2009-09-25T16:53:58Z,E9-23170,0,0,0900006480a2c12d
FDA-2009-N-0026-0006,FDA,FDA-2009-N-0026,Courtesy Letter from FDA/Division of Dockets Management,Other,Letter(s),2009-02-11T05:00:00Z,2009,2,2023-12-19T05:00:00Z,,2023-12-19T18:12:20Z,,0,0,0900006480854821
FDA-2009-N-0026-0001,FDA,FDA-2009-N-0026,Apothecon et al.; Withdrawal of Approval of 103 New Drug Applications and 35 Abbreviated New Drug Applications,Notice,NWL-Notice of Withdrawl,2009-02-11T05:00:00Z,2009,2,2009-02-11T05:00:00Z,,2009-02-11T20:00:57Z,E9-02901,0,0,09000064808525b4